Prenatal STI Screening Twice During Pregnancy Cuts Preterm Birth Risk by 23%
A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
A peer-reviewed study reports ACES Diagnostics’ LymeSeek immunoassay achieved 90% sensitivity for early Lyme disease detection within two weeks of symptom onset.
Co-Diagnostics has installed two Vector Smart PCR mosquito surveillance labs in Florida and begun setup in Indiana, expanding its network to 21 states amid reports of 73 local dengue cases.
Alveo Technologies and UTMB have partnered to develop point-of-care diagnostics for Lassa fever, deploying molecular sensing platforms at clinical sites in Nigeria and Sierra Leone to support real-time pathogen detection.
Co-Diagnostics has submitted a Dual 510(k) and CLIA waiver application to the FDA for its PCR-based flu and RSV test, aiming to enable point-of-care use on the Co-Dx PCR Pro instrument.
Roche has launched two new research PCR assays for Cyclospora cayetanensis detection, expanding lab testing options amid a US outbreak and adding flexibility for gastrointestinal pathogen research.
A Quest Diagnostics study of 1.5 million women found those with bacterial vaginosis are over three times more likely to have a non-viral STI, highlighting the need for comprehensive diagnostic testing.